Following the first approval of generic versions of type 2 diabetes drug, Actos, the FDA has also approved updated prescribing information for Tradjenta tablets, for add-on therapy to insulin ...

Please note that Kisqali is already approved for the treatment of metastatic breast cancer (MBC) in several countries. The EC approval followed the recent FDA approval of Kisqali for EBC patients ...

Please note that Kisqali is already approved for the treatment of metastatic breast cancer (MBC) in several countries. The EC approval followed the recent FDA approval of Kisqali for EBC patients and ...

In the second approval, the FDA has lifted the restriction to post ... are playing catch-up in the category with Novartis’ Kisqali (ribociclib), which got a green light four years ago following ...

In early 2023, Merck Animal Health also announced FDA approval of use of fluralaner chewable tablet (Bravecto for Dogs) for 12 weeks with Asian longhorned tick infestation. That expanded product label ...

This news follows the recent U.S. Food and Drug Administration (FDA) approval of Kisqali for EBC patients and recommendation as a Category 1 preferred breast cancer adjuvant treatment by the National ...

Nov. 29, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered health informatics, has received expanded FDA 510(k ...

The FDA was sued by two e-cigarette manufacturers after the agency denied their marketing applications in 2021. The manufacturers, Triton Distribution and Vapetasia, argued that the FDA unfairly ...